摘要
目的:研究5-氨基水杨酸(5-ASA)的跨膜转运是否涉及P-糖蛋白和多药耐药蛋白(MRP2)。方法:以Caco-2、L-MDR1、MRP2等三种细胞为模型,测定5-ASA跨膜转运的转运率和表观渗透常数。此外还研究了5-ASA对地高辛在Caco-2细胞转运的影响。结果:在Caco-2、L-MDR1和MRP2细胞,5、50、500gmol·L^-1 5-ASA从底端(B)→顶端(A)方向和A→B方向的转运率和表观渗透系数(Papp)均无统计学差异(P〉0.05)。在Caco-2细胞,与未用5-ASA组相比,各浓度5-ASA组(50μmol·L^-1~5mmol·L^-1)对地高辛的Papp和B→A方向的净转运率无明显影响(P〉0.05)。结论:5-ASA可能不是P-糖蛋白和MRP2的底物,也不能提示5-ASA是P-糖蛋白的抑制剂或诱导剂。
AIM: To investigate whether P-glycoprotein and MRP2 are involved in transport of 5-aminosalieylate ( 5-ASA ). METHODS: Permeability coefficients and transport rates of 5-ASA across Caco-2, L-MDR1 and MRP2 monolayers were measured. Trans epithelial transport of digoxin across Caco-2 monolayer with addition of 5-ASA was also studied. RESULTS: No differences of permeability coefficients and transport rates of 5-ASA at 5, 50 and 500 μmol·L^-1 between basal-to-apical and apical-to-basal direction were measurable across Caco-2, L-MDR1 and MRP2 monolayers ( P 〉 0.05 ). Compared with control experiments, no significant differences were observed in basal-to-apical net transport and Papp of digoxin (5 μmol·L^-1) in the presence of 5-ASA (50 μmol· L^-1 - 5 mmol·L^- 1 ) ( p 〉 0.05 ). CONCLUSION: 5-ASA can not be regarded as a substmte of P-gp or MRP2. Inhibition or induction of P-glycoprotein by 5- ASA could be excluded. Further studies are needed to identify the nature of the involved active carrier system(s) in intestinal secretion of 5-ASA.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2006年第11期1265-1269,共5页
Chinese Journal of Clinical Pharmacology and Therapeutics
基金
德国RobertBosch基金资助项目